Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network
BMC Medical Research Methodology, vol. 22, pp. 35
Abstract
BACKGROUND: We investigated whether we could use influenza data to develop prediction models for COVID-19 to increase the speed at which prediction models can reliably be developed and validated early in a pandemic. We developed COVID-19 Estimated Risk (COVER) scores that quantify a patient's risk of hospital admission with pneumonia (COVER-H), hospitalization with pneumonia requiring intensive services or death (COVER-I), or fatality (COVER-F) in the 30-days following COVID-19 diagnosis using historical data from patients with influenza or flu-like symptoms and tested this in COVID-19 patients. METHODS: We analyzed a federated network of electronic medical records and administrative claims data from 14 data sources and 6 countries containing data collected on or before 4/27/2020. We used a 2-step process to develop 3 scores using historical data from patients with influenza or flu-like symptoms any time prior to 2020. The first step was to create a data-driven model using LASSO regularized logistic regression, the covariates of which were used to develop aggregate covariates for the second step where the COVER scores were developed using a smaller set of features. These 3 COVER scores were then externally validated on patients with 1) influenza or flu-like symptoms and 2) confirmed or suspected COVID-19 diagnosis across 5 databases from South Korea, Spain, and the United States. Outcomes included i) hospitalization with pneumonia, ii) hospitalization with pneumonia requiring intensive services or death, and iii) death in the 30 days after index date. RESULTS: Overall, 44,507 COVID-19 patients were included for model validation. We identified 7 predictors (history of cancer, chronic obstructive pulmonary disease, diabetes, heart disease, hypertension, hyperlipidemia, kidney disease) which combined with age and sex discriminated which patients would experience any of our three outcomes. The models achieved good performance in influenza and COVID-19 cohorts. For COVID-19 the AUC ranges were, COVER-H: 0.69-0.81, COVER-I: 0.73-0.91, and COVER-F: 0.72-0.90. Calibration varied across the validations with some of the COVID-19 validations being less well calibrated than the influenza validations. CONCLUSIONS: This research demonstrated the utility of using a proxy disease to develop a prediction model. The 3 COVER models with 9-predictors that were developed using influenza data perform well for COVID-19 patients for predicting hospitalization, intensive services, and fatality. The scores showed good discriminatory performance which transferred well to the COVID-19 population. There was some miscalibration in the COVID-19 validations, which is potentially due to the difference in symptom severity between the two diseases. A possible solution for this is to recalibrate the models in each location before use.
Authors 48
-
Erasmus MC · Erasmus University Rotterdam
Affiliation as printed
Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein, 403015, GD, Rotterdam, The Netherlands
-
Erasmus MC · Erasmus University Rotterdam
Affiliation as printed
Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein, 403015, GD, Rotterdam, The Netherlands
-
Erasmus MC · Erasmus University Rotterdam
Affiliation as printed
Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein, 403015, GD, Rotterdam, The Netherlands
-
Institut Universitari d'Investigació en Atenció Primària Jordi Gol
Affiliation as printed
Fundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
-
Affiliation as printed
Department of Veterans Affairs, University of Utah, Salt Lake City, UT, USA
-
Affiliation as printed
Department of Biomedical Informatics, Columbia University, New York, NY, USA
-
Affiliation as printed
School of Public Health and Community Medicine, UNSW, Sydney, Australia
-
Affiliation as printed
Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea
-
National Health Insurance Service
Affiliation as printed
Department of Big Data Strategy, National Health Insurance Service, Wonju, Republic of Korea
-
Affiliation as printed
Tufts University School of Medicine, Institute for Clinical Research and Health Policy Studies, Boston, MA, 02111, USA
-
Affiliation as printed
Independent Epidemiologist, OHDSI, Rotterdam, The Netherlands
-
Affiliation as printed
So Ahn Public Health Center, Wando County Health Center and Hospital, Wando, Republic of Korea
-
Institut Universitari d'Investigació en Atenció Primària Jordi Gol
Affiliation as printed
Fundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
-
Affiliation as printed
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
-
University of Oxford · Institut Universitari d'Investigació en Atenció Primària Jordi Gol
Affiliation as printed
Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, UK
Fundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
-
Affiliation as printed
Department of Infectious Diseases, Ajou University School of Medicine, Suwon, Republic of Korea
-
Affiliation as printed
Center for Surgical Science, Koege, Denmark
-
Affiliation as printed
Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil
-
Institut Universitari d'Investigació en Atenció Primària Jordi Gol
Affiliation as printed
Fundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
-
Affiliation as printed
Department of Biomedical Informatics, Columbia University, New York, NY, USA
-
University of Copenhagen · Zealand University Hospital
Affiliation as printed
Clinical Pharmacology Unit, Zealand University Hospital, Roskilde, Denmark
NNF Centre for Protein Research, University of Copenhagen, Copenhagen, Denmark
-
Affiliation as printed
Abbvie, Chicago, USA
-
Erasmus MC · Erasmus University Rotterdam
Affiliation as printed
Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein, 403015, GD, Rotterdam, The Netherlands
-
Affiliation as printed
Real World Solutions, IQVIA, Cambridge, MA, USA
-
Affiliation as printed
School of Public Health and Community Medicine, UNSW, Sydney, Australia
-
Affiliation as printed
Department of Veterans Affairs, University of Utah, Salt Lake City, UT, USA
-
Affiliation as printed
Janssen Latin America, Buenos Aires, Argentina
-
United States Department of Veterans Affairs · Vanderbilt University · Veterans Health Administration
Affiliation as printed
Department of Veterans Affairs, Washington D. C, USA
Vanderbilt University, Nashville, USA
-
Affiliation as printed
Division of Population Health and Genomics, University of Dundee, Dundee, UK
-
Affiliation as printed
School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
-
Affiliation as printed
Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea
-
Affiliation as printed
Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, UK
-
Affiliation as printed
Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, Australia
-
Affiliation as printed
Janssen Research & Development, Titusville, NJ, USA
-
Affiliation as printed
Real World Solutions, IQVIA, Cambridge, MA, USA
-
Affiliation as printed
Bayer Pharmaceuticals, Bayer Hispania, S.L., Barcelona, Spain
-
Erasmus MC · Erasmus University Rotterdam
Affiliation as printed
Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein, 403015, GD, Rotterdam, The Netherlands
-
Affiliation as printed
Janssen Research & Development, Titusville, NJ, USA
-
Affiliation as printed
Department of Biomedical Informatics, Columbia University, New York, NY, USA
-
Leiden University Medical Center · Erasmus MC
Affiliation as printed
Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands
Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands
-
University of California, Los Angeles
Affiliation as printed
Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, CA, USA
-
Affiliation as printed
Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea
-
The University of Melbourne · Chinese Academy of Medical Sciences & Peking Union Medical College
Affiliation as printed
Melbourne School of Public Health, The University of Melbourne, Melbourne, Victoria, Australia
School of Public Health, Peking Union Medical College, Beijing, China
-
Affiliation as printed
Abbvie, Chicago, USA
-
Affiliation as printed
Janssen Research & Development, Titusville, NJ, USA
-
Affiliation as printed
Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, UK
-
Affiliation as printed
Janssen Research & Development, Titusville, NJ, USA
-
Peter R. Rijnbeek corresponding
Erasmus MC · Erasmus University Rotterdam
Affiliation as printed
Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein, 403015, GD, Rotterdam, The Netherlands. p.rijnbeek@erasmusmc.nl
Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein, 403015, GD, Rotterdam, The Netherlands
Cited by 44 stored of 44
No patents citing this paper on Lens.org (checked 2026-10-11).
References 17
-
W3021170406details pending0citations
17 results